{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:10:10Z","timestamp":1783987810148,"version":"3.55.0"},"reference-count":113,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":95,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS138259"],"award-info":[{"award-number":["R01NS138259"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS138259"],"award-info":[{"award-number":["R01NS138259"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Eye, Ear, Nose & Throat (EENT) Foundation of New Orleans"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-026-09931-1","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T10:03:01Z","timestamp":1775815381000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Elovanoid neuroprotection targets cell transcriptomics and proteomics to sustain synaptic integrity after brain injury"],"prefix":"10.1038","volume":"9","author":[{"given":"Brian L.","family":"Giles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0185-553X","authenticated-orcid":false,"given":"Surjyadipta","family":"Bhattacharjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff X.","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranab K.","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludmila","family":"Belayev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos M.","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9243-5444","authenticated-orcid":false,"given":"Nicolas G.","family":"Bazan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,10]]},"reference":[{"key":"9931_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.emc.2022.09.014","volume":"41","author":"VR Salasky","year":"2023","unstructured":"Salasky, V. R. & Chang, W.-T. W. Neurotrauma update. Emerg. Med. Clin. North Am. 41, 19\u201333 (2023).","journal-title":"Emerg. Med. Clin. North Am."},{"key":"9931_CR2","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1089\/neu.2021.0038","volume":"38","author":"AR Rabinowitz","year":"2021","unstructured":"Rabinowitz, A. R. et al. Aging with traumatic brain injury: deleterious effects of injury chronicity are most pronounced in later life. J. Neurotrauma 38, 2706\u20132713 (2021).","journal-title":"J. Neurotrauma"},{"key":"9931_CR3","unstructured":"Georges, A. & Das, J. M. Traumatic Brain Injury (Archive). In StatPearls (StatPearls Publishing, 2025)."},{"key":"9931_CR4","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.3390\/biomedicines10102472","volume":"10","author":"AT Alouani","year":"2022","unstructured":"Alouani, A. T. & Elfouly, T. Traumatic brain injury (TBI) detection: past, present, and future. Biomedicines 10, 2472 (2022).","journal-title":"Biomedicines"},{"key":"9931_CR5","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/S1474-4422(22)00309-X","volume":"21","author":"AIR Maas","year":"2022","unstructured":"Maas, A. I. R. et al. Traumatic brain injury: progress and challenges in prevention, clinical care, and research. Lancet Neurol. 21, 1004\u20131060 (2022).","journal-title":"Lancet Neurol."},{"key":"9931_CR6","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1001\/jamaneurol.2016.1948","volume":"73","author":"PK Crane","year":"2016","unstructured":"Crane, P. K. et al. Association of traumatic brain injury with late-life neurodegenerative conditions and neuropathologic findings. JAMA Neurol. 73, 1062\u20131069 (2016).","journal-title":"JAMA Neurol."},{"key":"9931_CR7","doi-asserted-by":"publisher","first-page":"1552527","DOI":"10.3389\/fnins.2025.1552527","volume":"19","author":"T Liu","year":"2025","unstructured":"Liu, T., Ma, L., Chen, Y. & Jiang, R. Editorial: neurodegeneration and cognitive impairment after traumatic brain injury. Front. Neurosci. 19, 1552527 (2025).","journal-title":"Front. Neurosci."},{"key":"9931_CR8","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3389\/fnhum.2013.00395","volume":"7","author":"ED Bigler","year":"2013","unstructured":"Bigler, E. D. Traumatic brain injury, neuroimaging, and neurodegeneration. Front. Hum. Neurosci. 7, 395 (2013).","journal-title":"Front. Hum. Neurosci."},{"key":"9931_CR9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ebiom.2018.01.021","volume":"28","author":"J Ramos-Cejudo","year":"2018","unstructured":"Ramos-Cejudo, J. et al. Traumatic brain injury and Alzheimer\u2019s disease: the cerebrovascular link. EBioMedicine 28, 21\u201330 (2018).","journal-title":"EBioMedicine"},{"key":"9931_CR10","doi-asserted-by":"publisher","first-page":"1239653","DOI":"10.3389\/fneur.2023.1239653","volume":"14","author":"WP Flavin","year":"2023","unstructured":"Flavin, W. P. et al. Traumatic brain injury and the pathways to cerebral tau accumulation. Front. Neurol. 14, 1239653 (2023).","journal-title":"Front. Neurol."},{"key":"9931_CR11","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.3390\/biomedicines11041154","volume":"11","author":"S Barker","year":"2023","unstructured":"Barker, S., Paul, B. D. & Pieper, A. A. Increased risk of aging-related neurodegenerative disease after traumatic brain injury. Biomedicines 11, 1154 (2023).","journal-title":"Biomedicines"},{"key":"9931_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-00870-x","volume":"11","author":"Y He","year":"2021","unstructured":"He, Y. et al. Increased VLCFA-lipids and ELOVL4 underlie neurodegeneration in frontotemporal dementia. Sci. Rep. 11, 21348 (2021).","journal-title":"Sci. Rep."},{"key":"9931_CR13","doi-asserted-by":"publisher","first-page":"101165","DOI":"10.1016\/j.plipres.2022.101165","volume":"86","author":"SC Dyall","year":"2022","unstructured":"Dyall, S. C. et al. Polyunsaturated fatty acids and fatty acid-derived lipid mediators: recent advances in the understanding of their biosynthesis, structures, and functions. Prog. Lipid Res. 86, 101165 (2022).","journal-title":"Prog. Lipid Res."},{"key":"9931_CR14","doi-asserted-by":"publisher","first-page":"e1700735","DOI":"10.1126\/sciadv.1700735","volume":"3","author":"S Bhattacharjee","year":"2017","unstructured":"Bhattacharjee, S. et al. Elovanoids are a novel class of homeostatic lipid mediators that protect neural cell integrity upon injury. Sci. Adv. 3, e1700735 (2017).","journal-title":"Sci. Adv."},{"key":"9931_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-05433-7","volume":"7","author":"B Jun","year":"2017","unstructured":"Jun, B. et al. Elovanoids are novel cell-specific lipid mediators necessary for neuroprotective signaling for photoreceptor cell integrity. Sci. Rep. 7, 5279 (2017).","journal-title":"Sci. Rep."},{"key":"9931_CR16","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.ajhg.2011.10.011","volume":"89","author":"MA Aldahmesh","year":"2011","unstructured":"Aldahmesh, M. A. et al. Recessive mutations in ELOVL4 cause ichthyosis, intellectual disability, and spastic quadriplegia.  Am. J. Hum. Genet. 89, 745\u2013750 (2011).","journal-title":"Am. J. Hum. Genet."},{"key":"9931_CR17","doi-asserted-by":"publisher","first-page":"5963","DOI":"10.1523\/JNEUROSCI.0378-23.2023","volume":"43","author":"RY Nagaraja","year":"2023","unstructured":"Nagaraja, R. Y., Stiles, M. A., Sherry, D. M., Agbaga, M.-P. & Ahmad, M. Synapse-specific defects in synaptic transmission in the cerebellum of W246G mutant ELOVL4 rats\u2014a model of human SCA34. J. Neurosci. 43, 5963\u20135974 (2023).","journal-title":"J. Neurosci."},{"key":"9931_CR18","doi-asserted-by":"publisher","first-page":"4921","DOI":"10.1007\/s12035-021-02439-1","volume":"58","author":"RY Nagaraja","year":"2021","unstructured":"Nagaraja, R. Y. et al. W246G mutant ELOVL4 impairs synaptic plasticity in parallel and climbing fibers and causes motor defects in a rat model of SCA34. Mol. Neurobiol. 58, 4921\u20134943 (2021).","journal-title":"Mol. Neurobiol."},{"key":"9931_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10985549.2023.2169563","volume":"43","author":"Y Tamura","year":"2023","unstructured":"Tamura, Y., Sassa, T., Nishizawa, T. & Kihara, A. Incomplete elongation of ultra-long-chain polyunsaturated acyl-CoAs by the fatty acid elongase ELOVL4 in spinocerebellar ataxia type 34. Mol. Cell. Biol. 43, 1\u201317 (2023).","journal-title":"Mol. Cell. Biol."},{"key":"9931_CR20","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1007\/s12035-017-0824-8","volume":"55","author":"BR Hopiavuori","year":"2018","unstructured":"Hopiavuori, B. R. et al. Homozygous expression of mutant ELOVL4 leads to seizures and death in a novel animal model of very long-chain fatty acid deficiency. Mol. Neurobiol. 55, 1795\u20131813 (2018).","journal-title":"Mol. Neurobiol."},{"key":"9931_CR21","doi-asserted-by":"publisher","first-page":"100317","DOI":"10.1016\/j.jlr.2022.100317","volume":"64","author":"YK Gyening","year":"2023","unstructured":"Gyening, Y. K. et al. ELOVL4 mutations that cause spinocerebellar ataxia-34 differentially alter very long chain fatty acid biosynthesis. J. Lipid Res. 64, 100317 (2023).","journal-title":"J. Lipid Res."},{"key":"9931_CR22","doi-asserted-by":"publisher","first-page":"428","DOI":"10.3389\/fncel.2019.00428","volume":"13","author":"F De\u00e1k","year":"2019","unstructured":"De\u00e1k, F., Anderson, R. E., Fessler, J. L. & Sherry, D. M. Novel cellular functions of very long chain-fatty acids: insight from ELOVL4 mutations. Front. Cell. Neurosci. 13, 428 (2019).","journal-title":"Front. Cell. Neurosci."},{"key":"9931_CR23","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.lfs.2017.12.025","volume":"195","author":"TP Crowe","year":"2018","unstructured":"Crowe, T. P., Greenlee, M. H. W., Kanthasamy, A. G. & Hsu, W. H. Mechanism of intranasal drug delivery directly to the brain. Life Sci. 195, 44\u201352 (2018).","journal-title":"Life Sci."},{"key":"9931_CR24","doi-asserted-by":"publisher","first-page":"956907","DOI":"10.3389\/fimmu.2022.956907","volume":"13","author":"T Chitnis","year":"2022","unstructured":"Chitnis, T. et al. Nasal administration of anti-CD3 monoclonal antibody modulates effector CD8+\u2009T cell function and induces a regulatory response in T cells in human subjects. Front. Immunol. 13, 956907 (2022).","journal-title":"Front. Immunol."},{"key":"9931_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-42126-w","volume":"13","author":"MM Reid","year":"2023","unstructured":"Reid, M. M. et al. Integrated inflammatory signaling landscape response after delivering Elovanoid free-fatty-acid precursors leading to experimental stroke neuroprotection. Sci. Rep. 13, 15841 (2023).","journal-title":"Sci. Rep."},{"key":"9931_CR26","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.3390\/biomedicines12112555","volume":"12","author":"NG Bazan","year":"2024","unstructured":"Bazan, N. G. et al. Elovanoids, a novel class of lipid mediators, are neuroprotective in a traumatic brain injury model in rats. Biomedicines 12, 2555 (2024).","journal-title":"Biomedicines"},{"key":"9931_CR27","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1002\/jnr.24746","volume":"99","author":"JP McGeown","year":"2021","unstructured":"McGeown, J. P., Hume, P. A., Theadom, A., Quarrie, K. L. & Borotkanics, R. Nutritional interventions to improve neurophysiological impairments following traumatic brain injury: a systematic review. J. Neurosci. Res. 99, 573\u2013603 (2021).","journal-title":"J. Neurosci. Res."},{"key":"9931_CR28","doi-asserted-by":"publisher","first-page":"20220277","DOI":"10.1515\/tnsci-2022-0277","volume":"14","author":"Y Wu","year":"2023","unstructured":"Wu, Y., Zhang, J., Feng, X. & Jiao, W. Omega-3 polyunsaturated fatty acids alleviate early brain injury after traumatic brain injury by inhibiting neuroinflammation and necroptosis. Transl. Neurosci. 14, 20220277 (2023).","journal-title":"Transl. Neurosci."},{"key":"9931_CR29","doi-asserted-by":"publisher","first-page":"555","DOI":"10.3727\/096368916X693842","volume":"26","author":"H Pu","year":"2017","unstructured":"Pu, H. et al. Repetitive and prolonged omega-3 fatty acid treatment after traumatic brain injury enhances long-term tissue restoration and cognitive recovery. Cell Transplant. 26, 555\u2013569 (2017).","journal-title":"Cell Transplant."},{"key":"9931_CR30","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.plefa.2014.05.008","volume":"92","author":"S Afshordel","year":"2015","unstructured":"Afshordel, S. et al. Omega-3 polyunsaturated fatty acids improve mitochondrial dysfunction in brain aging-impact of Bcl-2 and NPD-1 like metabolites. Prostaglandins Leukot. Essent. Fat. Acids 92, 23\u201331 (2015).","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"9931_CR31","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1146\/annurev.nutr.012809.104635","volume":"31","author":"NG Bazan","year":"2011","unstructured":"Bazan, N. G., Molina, M. F. & Gordon, W. C. Docosahexaenoic acid signalolipidomics in nutrition: significance in aging, neuroinflammation, macular degeneration, Alzheimer\u2019s, and other neurodegenerative diseases. Annu. Rev. Nutr. 31, 321\u2013351 (2011).","journal-title":"Annu. Rev. Nutr."},{"key":"9931_CR32","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1080\/1028415X.2016.1236174","volume":"21","author":"BP Lucke-Wold","year":"2018","unstructured":"Lucke-Wold, B. P. et al. Supplements, nutrition, and alternative therapies for the treatment of traumatic brain injury. Nutr. Neurosci. 21, 79\u201391 (2018).","journal-title":"Nutr. Neurosci."},{"key":"9931_CR33","doi-asserted-by":"publisher","first-page":"5564","DOI":"10.1007\/s12035-021-02501-y","volume":"58","author":"K Mondal","year":"2021","unstructured":"Mondal, K. et al. Systemic elevation of n-3 polyunsaturated fatty acids (n-3-PUFA) is associated with protection against visual, motor, and emotional deficits in mice following closed-head mild traumatic brain injury. Mol. Neurobiol. 58, 5564\u20135580 (2021).","journal-title":"Mol. Neurobiol."},{"key":"9931_CR34","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1073\/pnas.86.8.2903","volume":"86","author":"BL Scott","year":"1989","unstructured":"Scott, B. L. & Bazan, N. G. Membrane docosahexaenoate is supplied to the developing brain and retina by the liver. PNAS 86, 2903\u20132907 (1989).","journal-title":"PNAS"},{"key":"9931_CR35","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1089\/neu.2013.3234","volume":"31","author":"AG Scrimgeour","year":"2014","unstructured":"Scrimgeour, A. G. & Condlin, M. L. Nutritional treatment for traumatic brain injury. J. Neurotrauma 31, 989\u2013999 (2014).","journal-title":"J. Neurotrauma"},{"key":"9931_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18035-1","volume":"11","author":"M Bentsen","year":"2020","unstructured":"Bentsen, M. et al. ATAC-seq footprinting unravels kinetics of transcription factor binding during zygotic genome activation. Nat. Commun. 11, 4267 (2020).","journal-title":"Nat. Commun."},{"key":"9931_CR37","doi-asserted-by":"publisher","first-page":"1015791","DOI":"10.1155\/2022\/1015791","volume":"2022","author":"A-G Wu","year":"2022","unstructured":"Wu, A.-G. et al. Targeting Nrf2-mediated oxidative stress response in traumatic brain injury: therapeutic perspectives of phytochemicals. Oxid. Med. Cell. Longev. 2022, 1015791 (2022).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"9931_CR38","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.pneurobio.2006.03.006","volume":"78","author":"G Raivich","year":"2006","unstructured":"Raivich, G. & Behrens, A. Role of the AP-1 transcription factor c-Jun in developing, adult and injured brain. Prog. Neurobiol. 78, 347\u2013363 (2006).","journal-title":"Prog. Neurobiol."},{"key":"9931_CR39","doi-asserted-by":"publisher","first-page":"42769","DOI":"10.1074\/jbc.M206911200","volume":"277","author":"H-C Huang","year":"2002","unstructured":"Huang, H.-C., Nguyen, T. & Pickett, C. B. Phosphorylation of Nrf2 at Ser-40 by protein kinase C regulates antioxidant response element-mediated transcription. J. Biol. Chem. 277, 42769\u201342774 (2002).","journal-title":"J. Biol. Chem."},{"key":"9931_CR40","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.freeradbiomed.2015.04.036","volume":"88","author":"AT Dinkova-Kostova","year":"2015","unstructured":"Dinkova-Kostova, A. T. & Abramov, A. Y. The emerging role of Nrf2 in mitochondrial function. Free Radic. Biol. Med. 88, 179\u2013188 (2015).","journal-title":"Free Radic. Biol. Med."},{"key":"9931_CR41","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1093\/brain\/awm095","volume":"130","author":"J Wang","year":"2007","unstructured":"Wang, J. & Dor\u00e9, S. Heme oxygenase-1 exacerbates early brain injury after intracerebral haemorrhage. Brain 130, 1643\u20131652 (2007).","journal-title":"Brain"},{"key":"9931_CR42","doi-asserted-by":"publisher","first-page":"1505S","DOI":"10.1093\/ajcn\/83.6.1505S","volume":"83","author":"PC Calder","year":"2006","unstructured":"Calder, P. C. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am. J. Clin. Nutr. 83, 1505S\u20131519S (2006).","journal-title":"Am. J. Clin. Nutr."},{"key":"9931_CR43","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.plefa.2010.02.006","volume":"82","author":"S Lay\u00e9","year":"2010","unstructured":"Lay\u00e9, S. Polyunsaturated fatty acids, neuroinflammation and well being. Prostaglandins Leukot. Essent. Fat. Acids 82, 295\u2013303 (2010).","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"9931_CR44","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.freeradbiomed.2018.06.031","volume":"124","author":"TS Anthonymuthu","year":"2018","unstructured":"Anthonymuthu, T. S., Kenny, E. M., Lamade, A. M., Kagan, V. E. & Bay\u0131r, H. Oxidized phospholipid signaling in traumatic brain injury. Free Radic. Biol. Med. 124, 493\u2013503 (2018).","journal-title":"Free Radic. Biol. Med."},{"key":"9931_CR45","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1089\/neu.2009.1210","volume":"27","author":"M Er\u015fahin","year":"2010","unstructured":"Er\u015fahin, M. et al. The anti-inflammatory and neuroprotective effects of ghrelin in subarachnoid hemorrhage-induced oxidative brain damage in rats. J. Neurotrauma 27, 1143\u20131155 (2010).","journal-title":"J. Neurotrauma"},{"key":"9931_CR46","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.3390\/antiox10111695","volume":"10","author":"WA Banks","year":"2021","unstructured":"Banks, W. A. & Rhea, E. M. The blood\u2013brain barrier, oxidative stress, and insulin resistance. Antioxidants (Basel) 10, 1695 (2021).","journal-title":"Antioxidants (Basel)"},{"key":"9931_CR47","doi-asserted-by":"publisher","first-page":"360438","DOI":"10.1155\/2014\/360438","volume":"2014","author":"A Ayala","year":"2014","unstructured":"Ayala, A., Mu\u00f1oz, M. F. & Arg\u00fcelles, S. Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid. Med. Cell. Longev. 2014, 360438 (2014).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"9931_CR48","doi-asserted-by":"publisher","first-page":"943","DOI":"10.3390\/antiox9100943","volume":"9","author":"H Ismail","year":"2020","unstructured":"Ismail, H. et al. Traumatic brain injury: oxidative stress and novel anti-oxidants such as mitoquinone and edaravone. Antioxidants (Basel) 9, 943 (2020).","journal-title":"Antioxidants (Basel)"},{"key":"9931_CR49","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1007\/s11064-020-03078-z","volume":"45","author":"W Zhu","year":"2020","unstructured":"Zhu, W. et al. Docosahexaenoic acid protects traumatic brain injury by regulating NOX2 generation via Nrf2 signaling pathway. Neurochem. Res. 45, 1839\u20131850 (2020).","journal-title":"Neurochem. Res."},{"key":"9931_CR50","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1007\/s10753-018-0765-z","volume":"41","author":"W Zhu","year":"2018","unstructured":"Zhu, W., Ding, Y., Kong, W., Li, T. & Chen, H. Docosahexaenoic acid (DHA) provides neuroprotection in traumatic brain injury models via activating Nrf2-ARE signaling. Inflammation 41, 1182\u20131193 (2018).","journal-title":"Inflammation"},{"key":"9931_CR51","doi-asserted-by":"publisher","first-page":"731","DOI":"10.3390\/antiox12030731","volume":"12","author":"H Cheng","year":"2023","unstructured":"Cheng, H. et al. Neuroprotection of NRF2 against ferroptosis after traumatic brain injury in mice. Antioxidants (Basel) 12, 731 (2023).","journal-title":"Antioxidants (Basel)"},{"key":"9931_CR52","doi-asserted-by":"publisher","first-page":"e36820","DOI":"10.1016\/j.heliyon.2024.e36820","volume":"10","author":"W Shao","year":"2024","unstructured":"Shao, W. et al. LFHP-1c improves cognitive function after TBI in mice by reducing oxidative stress through the PGAM5\u2013NRF2\u2013KEAP1 ternary complex. Heliyon 10, e36820 (2024).","journal-title":"Heliyon"},{"key":"9931_CR53","doi-asserted-by":"publisher","first-page":"103355","DOI":"10.1016\/j.redox.2024.103355","volume":"77","author":"M Sato","year":"2024","unstructured":"Sato, M. et al. Sensor systems of KEAP1 uniquely detecting oxidative and electrophilic stresses separately in vivo. Redox. Biol. 77, 103355 (2024).","journal-title":"Redox. Biol."},{"key":"9931_CR54","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1074\/jbc.M210664200","volume":"278","author":"EC Pietsch","year":"2003","unstructured":"Pietsch, E. C., Chan, J. Y., Torti, F. M. & Torti, S. V. Nrf2 mediates the induction of ferritin H in response to xenobiotics and cancer chemopreventive dithiolethiones. J. Biol. Chem. 278, 2361\u20132369 (2003).","journal-title":"J. Biol. Chem."},{"key":"9931_CR55","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.3390\/antiox11122345","volume":"11","author":"V Ngo","year":"2022","unstructured":"Ngo, V. & Duennwald, M. L. Nrf2 and oxidative stress: a general overview of mechanisms and implications in human disease. Antioxidants (Basel) 11, 2345 (2022).","journal-title":"Antioxidants (Basel)"},{"key":"9931_CR56","doi-asserted-by":"publisher","first-page":"8171","DOI":"10.1074\/jbc.M109.031575","volume":"285","author":"S Kapeta","year":"2010","unstructured":"Kapeta, S., Chondrogianni, N. & Gonos, E. S. Nuclear erythroid factor 2-mediated proteasome activation delays senescence in human fibroblasts. J. Biol. Chem. 285, 8171\u20138184 (2010).","journal-title":"J. Biol. Chem."},{"key":"9931_CR57","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.freeradbiomed.2021.10.020","volume":"177","author":"M Delgobo","year":"2021","unstructured":"Delgobo, M. et al. Thioredoxin reductase-1 levels are associated with NRF2 pathway activation and tumor recurrence in non-small cell lung cancer. Free Radic. Biol. Med. 177, 58\u201371 (2021).","journal-title":"Free Radic. Biol. Med."},{"key":"9931_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06334-6","volume":"14","author":"JM Calandria","year":"2023","unstructured":"Calandria, J. M. et al. Elovanoid-N34 modulates TXNRD1 key in protection against oxidative stress-related diseases. Cell Death Dis. 14, 819 (2023).","journal-title":"Cell Death Dis."},{"key":"9931_CR59","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.freeradbiomed.2022.07.013","volume":"189","author":"N Esteras","year":"2022","unstructured":"Esteras, N. & Abramov, A. Y. Nrf2 as a regulator of mitochondrial function: energy metabolism and beyond. Free Radic. Biol. Med. 189, 136\u2013153 (2022).","journal-title":"Free Radic. Biol. Med."},{"key":"9931_CR60","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3389\/fnsys.2016.00029","volume":"10","author":"TD Fischer","year":"2016","unstructured":"Fischer, T. D. et al. Altered mitochondrial dynamics and TBI pathophysiology. Front. Syst. Neurosci. 10, 29 (2016).","journal-title":"Front. Syst. Neurosci."},{"key":"9931_CR61","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/MAJ.0000000000000506","volume":"350","author":"JB Hiebert","year":"2015","unstructured":"Hiebert, J. B., Shen, Q., Thimmesch, A. R. & Pierce, J. D. Traumatic brain injury and mitochondrial dysfunction. Am. J. Med. Sci. 350, 132\u2013138 (2015).","journal-title":"Am. J. Med. Sci."},{"key":"9931_CR62","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1038\/nn.3195","volume":"15","author":"J Ji","year":"2012","unstructured":"Ji, J. et al. Lipidomics identifies cardiolipin oxidation as a mitochondrial target for redox therapy of brain injury. Nat. Neurosci. 15, 1407\u20131413 (2012).","journal-title":"Nat. Neurosci."},{"key":"9931_CR63","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1089\/neu.2018.5990","volume":"36","author":"WB Hubbard","year":"2019","unstructured":"Hubbard, W. B. et al. Acute mitochondrial impairment underlies prolonged cellular dysfunction after repeated mild traumatic brain injuries. J. Neurotrauma 36, 1252\u20131263 (2019).","journal-title":"J. Neurotrauma"},{"key":"9931_CR64","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1038\/sj.jcbfm.9600297","volume":"26","author":"IN Singh","year":"2006","unstructured":"Singh, I. N., Sullivan, P. G., Deng, Y., Mbye, L. H. & Hall, E. D. Time course of post-traumatic mitochondrial oxidative damage and dysfunction in a mouse model of focal traumatic brain injury: implications for neuroprotective therapy. J. Cereb. Blood Flow Metab. 26, 1407\u20131418 (2006).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"9931_CR65","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.3233\/JAD-200720","volume":"78","author":"Z Si","year":"2020","unstructured":"Si, Z. & Wang, X. The neuroprotective and neurodegeneration effects of heme oxygenase-1 in Alzheimer\u2019s disease. J. Alzheimers Dis. 78, 1259\u20131272 (2020).","journal-title":"J. Alzheimers Dis."},{"key":"9931_CR66","doi-asserted-by":"publisher","first-page":"7041","DOI":"10.3390\/ijms23137041","volume":"23","author":"YK Choi","year":"2022","unstructured":"Choi, Y. K. & Kim, Y.-M. Beneficial and detrimental roles of heme oxygenase-1 in the neurovascular system. Int. J. Mol. Sci. 23, 7041 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"9931_CR67","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1016\/j.freeradbiomed.2012.03.020","volume":"52","author":"E Barone","year":"2012","unstructured":"Barone, E. et al. Heme oxygenase-1 posttranslational modifications in the brain of subjects with Alzheimer disease and mild cognitive impairment. Free Radic. Biol. Med. 52, 2292\u20132301 (2012).","journal-title":"Free Radic. Biol. Med."},{"key":"9931_CR68","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1089\/089771503770195821","volume":"20","author":"JW Huh","year":"2003","unstructured":"Huh, J. W., Raghupathi, R., Laurer, H. L., Helfaer, M. A. & Saatman, K. E. Transient loss of microtubule-associated protein 2 immunoreactivity after moderate brain injury in mice. J. Neurotrauma 20, 975\u2013984 (2003).","journal-title":"J. Neurotrauma"},{"key":"9931_CR69","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.3171\/2010.3.JNS091212","volume":"113","author":"C Wakade","year":"2010","unstructured":"Wakade, C., Sukumari-Ramesh, S., Laird, M. D., Dhandapani, K. M. & Vender, J. R. Delayed reduction in hippocampal postsynaptic density protein-95 expression temporally correlates with cognitive dysfunction following controlled cortical impact in mice. J. Neurosurg. 113, 1195\u20131201 (2010).","journal-title":"J. Neurosurg."},{"key":"9931_CR70","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1089\/neu.2007.0451","volume":"25","author":"MA Ansari","year":"2008","unstructured":"Ansari, M. A., Roberts, K. N. & Scheff, S. W. A time course of contusion-induced oxidative stress and synaptic proteins in cortex in a rat model of TBI. J. Neurotrauma 25, 513\u2013526 (2008).","journal-title":"J. Neurotrauma"},{"key":"9931_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-90925-0","volume":"15","author":"N Keller","year":"2025","unstructured":"Keller, N., Christensen, T. A., Wanberg, E. J., Salisbury, J. L. & Trushina, E. Neuroprotective mitochondria targeted small molecule restores synapses and the distribution of synaptic mitochondria in the hippocampus of APP\/PS1 mice. Sci. Rep. 15, 6528 (2025).","journal-title":"Sci. Rep."},{"key":"9931_CR72","doi-asserted-by":"publisher","DOI":"10.1186\/s13041-020-00582-9","volume":"13","author":"R Rauti","year":"2020","unstructured":"Rauti, R. et al. BDNF impact on synaptic dynamics: extra or intracellular long-term release differently regulates cultured hippocampal synapses. Mol. Brain 13, 43 (2020).","journal-title":"Mol. Brain"},{"key":"9931_CR73","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41583-020-00415-7","volume":"22","author":"AM Gomez","year":"2021","unstructured":"Gomez, A. M., Traunm\u00fcller, L. & Scheiffele, P. Neurexins: molecular codes for shaping neuronal synapses. Nat. Rev. Neurosci. 22, 137\u2013151 (2021).","journal-title":"Nat. Rev. Neurosci."},{"key":"9931_CR74","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/nrn2392","volume":"9","author":"L Mei","year":"2008","unstructured":"Mei, L. & Xiong, W.-C. Neuregulin 1 in neural development, synaptic plasticity and schizophrenia. Nat. Rev. Neurosci. 9, 437\u2013452 (2008).","journal-title":"Nat. Rev. Neurosci."},{"key":"9931_CR75","doi-asserted-by":"publisher","first-page":"11274","DOI":"10.1523\/JNEUROSCI.1774-14.2014","volume":"34","author":"GP Demyanenko","year":"2014","unstructured":"Demyanenko, G. P. et al. Neural cell adhesion molecule NrCAM regulates Semaphorin 3F-induced dendritic spine remodeling. J. Neurosci. 34, 11274\u201311287 (2014).","journal-title":"J. Neurosci."},{"key":"9931_CR76","doi-asserted-by":"publisher","first-page":"8088","DOI":"10.1523\/JNEUROSCI.0454-20.2020","volume":"40","author":"KJ Gan","year":"2020","unstructured":"Gan, K. J. & S\u00fcdhof, T. C. SPARCL1 promotes excitatory but not inhibitory synapse formation and function independent of neurexins and neuroligins. J. Neurosci. 40, 8088\u20138102 (2020).","journal-title":"J. Neurosci."},{"key":"9931_CR77","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3164\/jcbn.22-71","volume":"72","author":"Y Ishihara","year":"2023","unstructured":"Ishihara, Y. & Itoh, K. Microglial inflammatory reactions regulated by oxidative stress. J. Clin. Biochem. Nutr. 72, 23\u201327 (2023).","journal-title":"J. Clin. Biochem. Nutr."},{"key":"9931_CR78","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.expneurol.2015.08.018","volume":"275","author":"DJ Loane","year":"2016","unstructured":"Loane, D. J. & Kumar, A. Microglia in the TBI brain: the good, the bad, and the dysregulated. Exp. Neurol. 275, 316\u2013327 (2016).","journal-title":"Exp. Neurol."},{"key":"9931_CR79","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.expneurol.2015.03.020","volume":"275","author":"JE Burda","year":"2016","unstructured":"Burda, J. E., Bernstein, A. M. & Sofroniew, M. V. Astrocyte roles in traumatic brain injury. Exp. Neurol. 275, 305\u2013315 (2016).","journal-title":"Exp. Neurol."},{"key":"9931_CR80","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/0092-8674(88)90076-1","volume":"54","author":"R Chiu","year":"1988","unstructured":"Chiu, R. et al. The c-Fos protein interacts with c-Jun\/AP-1 to stimulate transcription of AP-1 responsive genes. Cell 54, 541\u2013552 (1988).","journal-title":"Cell"},{"key":"9931_CR81","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1523\/JNEUROSCI.15-03-02030.1995","volume":"15","author":"PK Dash","year":"1995","unstructured":"Dash, P. K., Moore, A. N. & Dixon, C. E. Spatial memory deficits, increased phosphorylation of the transcription factor CREB, and induction of the AP-1 complex following experimental brain injury. J. Neurosci. 15, 2030\u20132039 (1995).","journal-title":"J. Neurosci."},{"key":"9931_CR82","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/0006-8993(94)91964-X","volume":"664","author":"K Yang","year":"1994","unstructured":"Yang, K. et al. Increased expression of c-fos mRNA and AP-1 transcription factors after cortical impact injury in rats. Brain Res. 664, 141\u2013147 (1994).","journal-title":"Brain Res."},{"key":"9931_CR83","doi-asserted-by":"publisher","first-page":"687","DOI":"10.3390\/neurosci3040050","volume":"3","author":"SY Lara Aparicio","year":"2022","unstructured":"Lara Aparicio, S. Y. et al. Current opinion on the use of c-Fos in neuroscience. NeuroScience 3, 687\u2013702 (2022).","journal-title":"NeuroScience"},{"key":"9931_CR84","doi-asserted-by":"publisher","first-page":"RP87258","DOI":"10.7554\/eLife.87258","volume":"12","author":"T Li","year":"2024","unstructured":"Li, T., Shi, W., Ho, M. S. & Zhang, Y. Q. A Pvr-AP-1-Mmp1 signaling pathway is activated in astrocytes upon traumatic brain injury. Elife 12, RP87258 (2024).","journal-title":"Elife"},{"key":"9931_CR85","doi-asserted-by":"publisher","unstructured":"Kosoy, R. et al. Alzheimer\u2019s disease transcriptional landscape in ex vivo human microglia. Nat. Neurosci. https:\/\/doi.org\/10.1038\/s41593-025-02020-2 (2025).","DOI":"10.1038\/s41593-025-02020-2"},{"key":"9931_CR86","doi-asserted-by":"publisher","first-page":"4980","DOI":"10.1016\/j.cell.2025.06.031","volume":"188","author":"Z Liu","year":"2025","unstructured":"Liu, Z. et al. Single-cell multiregion epigenomic rewiring in Alzheimer\u2019s disease progression and cognitive resilience. Cell 188, 4980\u20135002.e29 (2025).","journal-title":"Cell"},{"key":"9931_CR87","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1002\/jnr.22227","volume":"88","author":"R Sultana","year":"2010","unstructured":"Sultana, R., Banks, W. A. & Butterfield, D. A. Decreased levels of PSD95 and two associated proteins and increased levels of BCl2 and caspase 3 in hippocampus from subjects with amnestic mild cognitive impairment: insights into their potential roles for loss of synapses and memory, accumulation of Abeta, and neurodegeneration in a prodromal stage of Alzheimer\u2019s disease. J. Neurosci. Res. 88, 469\u2013477 (2010).","journal-title":"J. Neurosci. Res."},{"key":"9931_CR88","doi-asserted-by":"publisher","first-page":"795","DOI":"10.3233\/JAD-2010-100090","volume":"21","author":"DT Proctor","year":"2010","unstructured":"Proctor, D. T., Coulson, E. J. & Dodd, P. R. Reduction in post-synaptic scaffolding PSD-95 and SAP-102 protein levels in the Alzheimer inferior temporal cortex is correlated with disease pathology. J. Alzheimers Dis. 21, 795\u2013811 (2010).","journal-title":"J. Alzheimers Dis."},{"key":"9931_CR89","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s00401-011-0843-x","volume":"122","author":"CY Shao","year":"2011","unstructured":"Shao, C. Y., Mirra, S. S., Sait, H. B. R., Sacktor, T. C. & Sigurdsson, E. M. Postsynaptic degeneration as revealed by PSD-95 reduction occurs after advanced A\u03b2 and tau pathology in transgenic mouse models of Alzheimer\u2019s disease. Acta Neuropathol. 122, 285\u2013292 (2011).","journal-title":"Acta Neuropathol."},{"key":"9931_CR90","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1093\/brain\/awu190","volume":"137","author":"JL Robinson","year":"2014","unstructured":"Robinson, J. L. et al. Perforant path synaptic loss correlates with cognitive impairment and Alzheimer\u2019s disease in the oldest-old. Brain 137, 2578\u20132587 (2014).","journal-title":"Brain"},{"key":"9931_CR91","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/ana.410300410","volume":"30","author":"RD Terry","year":"1991","unstructured":"Terry, R. D. et al. Physical basis of cognitive alterations in Alzheimer\u2019s disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 30, 572\u2013580 (1991).","journal-title":"Ann. Neurol."},{"key":"9931_CR92","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/ana.410270502","volume":"27","author":"ST DeKosky","year":"1990","unstructured":"DeKosky, S. T. & Scheff, S. W. Synapse loss in frontal cortex biopsies in Alzheimer\u2019s disease: correlation with cognitive severity. Ann. Neurol. 27, 457\u2013464 (1990).","journal-title":"Ann. Neurol."},{"key":"9931_CR93","doi-asserted-by":"publisher","first-page":"1214450","DOI":"10.3389\/fcell.2023.1214450","volume":"11","author":"Y Xinchen","year":"2023","unstructured":"Xinchen, Y., Jing, T. & Jiaoqiong, G. Lipid-based nanoparticles via nose-to-brain delivery: a mini review. Front. Cell Dev. Biol. 11, 1214450 (2023).","journal-title":"Front. Cell Dev. Biol."},{"key":"9931_CR94","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s42003-022-03169-3","volume":"5","author":"C Emre","year":"2022","unstructured":"Emre, C. et al. Intranasal delivery of pro-resolving lipid mediators rescues memory and gamma oscillation impairment in AppNL-G-F\/NL-G-F mice. Commun. Biol. 5, 245 (2022).","journal-title":"Commun. Biol."},{"key":"9931_CR95","doi-asserted-by":"publisher","first-page":"838","DOI":"10.3390\/antiox11050838","volume":"11","author":"C Zussy","year":"2022","unstructured":"Zussy, C. et al. Intranasal Administration of nanovectorized docosahexaenoic acid (DHA) improves cognitive function in two complementary mouse models of Alzheimer\u2019s disease. Antioxidants (Basel) 11, 838 (2022).","journal-title":"Antioxidants (Basel)"},{"key":"9931_CR96","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s00210-021-02196-x","volume":"395","author":"F Moradi","year":"2022","unstructured":"Moradi, F. & Dashti, N. Targeting neuroinflammation by intranasal delivery of nanoparticles in neurological diseases: a comprehensive review. Naunyn Schmiedebergs Arch. Pharmacol. 395, 133\u2013148 (2022).","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"9931_CR97","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/s41576-023-00586-w","volume":"24","author":"L Heumos","year":"2023","unstructured":"Heumos, L. et al. Best practices for single-cell analysis across modalities. Nat. Rev. Genet. 24, 550\u2013572 (2023).","journal-title":"Nat. Rev. Genet."},{"key":"9931_CR98","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/jnr.24405","volume":"98","author":"A Jullienne","year":"2020","unstructured":"Jullienne, A. et al. Acute intranasal osteopontin treatment in male rats following TBI increases the number of activated microglia but does not alter lesion characteristics. J. Neurosci. Res. 98, 141\u2013154 (2020).","journal-title":"J. Neurosci. Res."},{"key":"9931_CR99","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/978-1-0716-0845-6_6","volume":"2193","author":"M-L Fournier","year":"2021","unstructured":"Fournier, M.-L. et al. Contusion rodent model of traumatic brain injury: controlled cortical impact. Methods Mol. Biol. 2193, 49\u201365 (2021).","journal-title":"Methods Mol. Biol."},{"key":"9931_CR100","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1089\/neu.2014.3611","volume":"32","author":"JL Rossi","year":"2015","unstructured":"Rossi, J. L., Todd, T., Daniels, Z., Bazan, N. G. & Belayev, L. Interferon-stimulated gene 15 upregulation precedes the development of blood\u2013brain barrier disruption and cerebral edema after traumatic brain injury in young mice. J. Neurotrauma 32, 1101\u20131108 (2015).","journal-title":"J. Neurotrauma"},{"key":"9931_CR101","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1080\/15287398609530835","volume":"17","author":"FJ Zeman","year":"1986","unstructured":"Zeman, F. J., Hoogenboom, E. R., Kavlock, R. J. & Semple, J. L. Effects on the fetus of maternal benomyl exposure in the protein-deprived rat. J. Toxicol. Environ. Health 17, 405\u2013417 (1986).","journal-title":"J. Toxicol. Environ. Health"},{"key":"9931_CR102","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1089\/neu.1999.16.445","volume":"16","author":"L Belayev","year":"1999","unstructured":"Belayev, L. et al. Posttreatment with high-dose albumin reduces histopathological damage and improves neurological deficit following fluid percussion brain injury in rats. J. Neurotrauma 16, 445\u2013453 (1999).","journal-title":"J. Neurotrauma"},{"key":"9931_CR103","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.bbr.2015.08.007","volume":"294","author":"TC Peterson","year":"2015","unstructured":"Peterson, T. C., Maass, W. R., Anderson, J. R., Anderson, G. D. & Hoane, M. R. A behavioral and histological comparison of fluid percussion injury and controlled cortical impact injury to the rat sensorimotor cortex. Behav. Brain Res. 294, 254\u2013263 (2015).","journal-title":"Behav. Brain Res."},{"key":"9931_CR104","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1038\/nmeth.4401","volume":"14","author":"AN Schep","year":"2017","unstructured":"Schep, A. N., Wu, B., Buenrostro, J. D. & Greenleaf, W. J. chromVAR: inferring transcription-factor-associated accessibility from single-cell epigenomic data. Nat. Methods 14, 975\u2013978 (2017).","journal-title":"Nat. Methods"},{"key":"9931_CR105","doi-asserted-by":"publisher","first-page":"101715","DOI":"10.1016\/j.xcrm.2024.101715","volume":"5","author":"PS Sridharan","year":"2024","unstructured":"Sridharan, P. S. et al. Acutely blocking excessive mitochondrial fission prevents chronic neurodegeneration after traumatic brain injury. Cell Rep. Med. 5, 101715 (2024).","journal-title":"Cell Rep. Med."},{"key":"9931_CR106","doi-asserted-by":"publisher","first-page":"eadn2635","DOI":"10.1126\/scitranslmed.adn2635","volume":"17","author":"N Liu","year":"2025","unstructured":"Liu, N. et al. Itaconate restrains acute proinflammatory activation of microglia after traumatic brain injury in mice. Sci. Transl. Med. 17, eadn2635 (2025).","journal-title":"Sci. Transl. Med."},{"key":"9931_CR107","doi-asserted-by":"publisher","first-page":"3788","DOI":"10.1093\/brain\/awab341","volume":"144","author":"WB Hubbard","year":"2021","unstructured":"Hubbard, W. B. et al. Clinically relevant mitochondrial-targeted therapy improves chronic outcomes after traumatic brain injury. Brain 144, 3788\u20133807 (2021).","journal-title":"Brain"},{"key":"9931_CR108","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1089\/neu.2023.0102","volume":"40","author":"WB Hubbard","year":"2023","unstructured":"Hubbard, W. B. et al. Mitochondrial dysfunction after repeated mild blast traumatic brain injury is attenuated by a mild mitochondrial uncoupling prodrug. J. Neurotrauma 40, 2396\u20132409 (2023).","journal-title":"J. Neurotrauma"},{"key":"9931_CR109","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-69867-2","volume":"10","author":"E Underwood","year":"2020","unstructured":"Underwood, E., Redell, J. B., Zhao, J., Moore, A. N. & Dash, P. K. A method for assessing tissue respiration in anatomically defined brain regions. Sci. Rep. 10, 13179 (2020).","journal-title":"Sci. Rep."},{"key":"9931_CR110","doi-asserted-by":"publisher","first-page":"e2401629","DOI":"10.1002\/adhm.202401629","volume":"14","author":"K Mouli","year":"2025","unstructured":"Mouli, K. et al. Oxidized carbon nanoparticles enhance cellular energetics with application to injured brain. Adv. Healthc. Mater. 14, e2401629 (2025).","journal-title":"Adv. Healthc. Mater."},{"key":"9931_CR111","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1089\/neu.2020.7379","volume":"38","author":"JD Pandya","year":"2021","unstructured":"Pandya, J. D. et al. Time-course evaluation of brain regional mitochondrial bioenergetics in a pre-clinical model of severe penetrating traumatic brain injury. J. Neurotrauma 38, 2323\u20132334 (2021).","journal-title":"J. Neurotrauma"},{"key":"9931_CR112","doi-asserted-by":"publisher","first-page":"105874","DOI":"10.1016\/j.neuint.2024.105874","volume":"180","author":"L Zima","year":"2024","unstructured":"Zima, L. et al. The evolving pathophysiology of TBI and the advantages of temporally-guided combination therapies. Neurochem. Int. 180, 105874 (2024).","journal-title":"Neurochem. Int."},{"key":"9931_CR113","doi-asserted-by":"publisher","first-page":"1570596","DOI":"10.3389\/fncel.2025.1570596","volume":"19","author":"OA Olatona","year":"2025","unstructured":"Olatona, O. A., Sterben, S. P., Kansakar, S. B. S., Symes, A. J. & Liaudanskaya, V. Mitochondria: the hidden engines of traumatic brain injury-driven neurodegeneration. Front. Cell. Neurosci. 19, 1570596 (2025).","journal-title":"Front. Cell. Neurosci."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09931-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09931-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09931-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:02:34Z","timestamp":1783987354000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09931-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,10]]},"references-count":113,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9931"],"URL":"https:\/\/doi.org\/10.1038\/s42003-026-09931-1","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,10]]},"assertion":[{"value":"11 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"948"}}